Mölnlycke Health Care to Exit the Barrier Surgical Drape and Gown Market
NEWTOWN, Pa. Earlier this year, APAX Partners acquired Mölnlycke Health Care, Inc. At that time it was announced that Mölnlycke Health Care would be merged with two other healthcare companies, Regent Medical and Medlock Medical, forming the Mölnlycke Health Care Group AB.
That merger has now been completed globally. As a part of the merger, a thorough business review was conducted; based on that work, the decision has been made to exit the Barrier Surgical Drapes and Gowns sector in the United States, South America, Latin America, and Canada in order to focus efforts and resources on the wound care, antiseptics, and surgical glove businesses. The Barrier wearing apparel line will be available and sold through distributors. This does not affect the drape and gown businesses in Europe or any other market area outside of the U.S., Canada, South America, and Latin America.
This was a difficult decision; however, we feel it is the right decision for the new organization, commented Dan Filippini, president and general manager of Mölnlycke Health Care US.
We greatly appreciate our customers loyalty and will do everything we can to make their transition to a new supplier as smooth and seamless as possible, commented John Sullivan, vice president of sales. Territory sales managers will be available to help with this transition. Current drape and gown customers will be supported in locating other options for their needs, in coordination with their distributors and/or custom tray suppliers.
The business transition is expected to be complete by the end of the year.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
